ArticleACS omega2025
Polysaccharide-Encapsulated Lauraceae Extract Complex Coating Conferring Antimicrobial Properties to Polypropylene Surfaces.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rise in antimicrobial resistance (AMR) pathogens necessitates innovative approaches for infection control, particularly in medical device applications. Moreover, simultaneously ensuring sustained antimicrobial activity in biomaterials and minimizing potential resistance development remain critical aspects that lack new strategies. This study presents the development and application of an innovative antimicrobial agent, that is, a multifunctional polysaccharide-encapsulated Lauraceae extract complex (PLEC) coating designed to enhance the antimicrobial efficacy and compatibility of polypropylene surfaces. The study findings indicate that the PLEC coating has potent antibacterial and antifungal characteristics, preventing a wide range of infections. A comprehensive analysis revealed significant reductions in bacterial colonies, including colonies of Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa), Gram-positive bacteria (Staphylococcus aureus and Streptococcus mitis), and various fungal strains. Moreover, cytotoxicity evaluations confirm the nontoxic nature of the coatings, ensuring their safety for medical use. This study demonstrates that multifunctional antimicrobial PLEC coatings offer a significant advancement in infection control strategies, providing an effective solution to the growing problem of AMR. The developed approach can be beneficial to the healthcare industry and society by reducing infection risks and treatment costs, ultimately improving clinical effectiveness and enhancing the efficacy of infection control measures in medical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.